lactic acid has been researched along with tocophersolan in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (20.00) | 29.6817 |
2010's | 35 (77.78) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Feng, SS; Mu, L | 2 |
Feng, SS; Mu, L; Ning, HZ; Tan, CS; Teo, MM | 1 |
Feng, SS; Zhang, Z | 1 |
Feng, SS; Win, KY | 1 |
Feng, SS; Huey Lee, S; Zhang, Z | 1 |
Chaw, CS; Yeung, E | 1 |
Yung, LY; Zhao, H | 1 |
Jung, GY; Myung, PK; Na, YE; Park, CS; Park, MS | 1 |
Feng, SS; Liu, Y; Pan, J | 1 |
Feng, SS; Zhao, L | 1 |
Dandekar, P; Hassan, PA; Jain, R; Pandey, U; Patravale, V; Samuel, G; Subramanian, S; Venkatesh, M | 1 |
Chen, HY; Hsu, CY; Huang, FH; Huang, LY; Lai, PS; Shieh, MJ | 1 |
Cheow, WS; Hadinoto, K | 1 |
Baek, JS; Cho, CW; Hwang, CJ; Keum, CG; Lim, JH; Na, YG; Noh, YW; Shin, SC | 1 |
Feng, SS; Liu, Y; Mi, Y; Zhao, J | 1 |
Ding, LY; Guo, M; Liu, YQ; Lu, Y; Ron, WT; Song, FF; Wang, Y; Yu, SQ | 1 |
Huang, B; Liu, CS; Wang, G; Wu, Y; Yu, B; Yuan, Y | 1 |
Huang, L; Liu, T; Mei, L; Ouyang, C; Tao, W; Wang, Z; Xiong, Q; Zeng, X | 1 |
Bu, S; Jiang, L; Xie, X; Yang, C; Zeng, Q; Zhang, L; Zheng, Y; Zhu, D | 1 |
Hascicek, C; Oz, UC; Serim, TM; Turk, CT | 1 |
Bera, T; Das, S; Halder, A; Mondal, S; Mukherjee, A; Roy, P | 1 |
Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH | 1 |
Ahmad, FJ; Anwar, M; Garg, V; Jain, GK; Khar, RK; Talegaonkar, S; Warsi, MH | 1 |
Chen, M; Fang, X; Li, Y; Wang, Y; Zhang, J; Zhou, D | 1 |
Chen, Y; Lee, RJ; Sun, Y; Tang, S; Teng, L; Wang, G; Wu, Y; Xu, S; Yu, B; Yuan, Y; Zhang, X | 1 |
Gao, Y; Li, J; Li, X; Liu, Y; Ma, S; Wang, D; Zhang, C; Zhao, L; Zhao, Y; Zhou, Y | 1 |
Hou, J; Lu, Y; Qi, SS; Rong, WT; Wang, DF; Xiao, Q; Xu, Q; You, J; Yu, SQ; Zhang, J | 1 |
Feng, X; Jin, X; Liang, Y; Sun, L; Tang, X; Zhang, R | 1 |
Chang, D; Chen, Y; Huang, L; Mei, L; Tao, W; Wang, T; Zeng, X; Zhang, J; Zhang, X | 1 |
Balasubramanian, S; Malathi, S; Nandhakumar, P; Pandiyan, V; Webster, TJ | 1 |
Huo, ZJ; Liu, K; Liu, P; Pang, B; Wang, SJ; Wang, ZQ; Zuo, WS | 1 |
Correia, IJ; Costa, EC; Gaspar, VM; Moreira, AF; Pichon, C; Queiroz, JA; Sousa, F | 1 |
Liu, G; Mei, L; Tao, W; Wang, T; Zeng, X; Zhang, H; Zhang, L; Zhu, D | 1 |
Cai, S; Chen, K; Liang, Y; Liu, L; Liu, X; Shen, J; Sui, X; Tan, Y; Tang, X; Wu, B; Xie, C; Yang, L; Zhang, C; Zhang, F; Zhang, M; Zhang, R; Zheng, D | 1 |
Cao, W; Chang, D; Chen, H; He, S; Mei, L; Shi, X; Tsai, HI; Wang, T; Wang, Y; Zeng, X; Zhang, R; Zhang, X; Zhu, X | 1 |
Di-Wen, S; Hao, L; Pan, GZ; Wang, P; Xue, QZ; Yuan, QZ; Zhang, J | 1 |
Chu, Q; Deng, S; Gao, M; Guan, X; Huo, X; Liu, H; Liu, K; Ma, X; Tian, Y; Xu, H | 1 |
Cheng, H; Guo, H; Li, C; Liu, G; Liu, X; Wang, Y; Zhang, F; Zhang, Y; Zhao, Z | 1 |
Liu, G; Mei, L; Sheng, Y; Tao, W; Xu, G; Yu, X; Zhang, J | 1 |
Bao, X; Deng, S; Gao, D; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Wang, C; Xu, H; Zhang, C | 1 |
Chen, H; Gui, YL; Huo, SJ; Kong, YY; Mu, X; Sun, JH; Xu, Q; Yu, SQ; Zhang, D; Zhou, M | 1 |
Akbas, S; Aktas, Y; Arslan, FB; Capan, Y; Colak, N; Guedon, I; Ozdemir, B; Ozdemir, S; Ozkan, T; Sahin, A; Sarcan, ET; Spiroux, F; Ultav, G; Yuksel, S | 1 |
Cheng, W; Huang, L; Liang, C; Liu, G; Mei, L; Nie, J; Peng, Y; Zeng, X; Zhang, L; Zhu, D | 1 |
Gui, S; Guo, J; He, N; Huang, Y; Li, Z; Liang, X; Tang, M; Tao, Y | 1 |
45 other study(ies) available for lactic acid and tocophersolan
Article | Year |
---|---|
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Delayed-Action Preparations; Lactic Acid; Nanotechnology; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Vitamin E | 2003 |
PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.
Topics: Delayed-Action Preparations; Drug Compounding; Emulsifying Agents; Lactic Acid; Nanotechnology; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Vitamin E | 2003 |
Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, High Pressure Liquid; Drug Compounding; Excipients; Lactic Acid; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powders; Solubility; Surface Properties; Vitamin E | 2005 |
Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Topics: Antineoplastic Agents, Phytogenic; Drug Carriers; Drug Therapy; Humans; Lactic Acid; Molecular Structure; Molecular Weight; Nanostructures; Neoplasms; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Surface Properties; Vitamin E | 2006 |
In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
Topics: Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Carriers; Drug Delivery Systems; Emulsifying Agents; Glycerol; Humans; Lactic Acid; Nanostructures; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface-Active Agents; Vitamin E | 2006 |
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery.
Topics: Animals; Breast Neoplasms; Capsules; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Diffusion; Drug Carriers; Folic Acid; Lactic Acid; Materials Testing; Mice; Nanostructures; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Vitamin E | 2007 |
Ciclosporin-loaded poly(lactide) microparticles: effect of TPGS.
Topics: Cyclosporine; Drug Carriers; Lactic Acid; Microspheres; Plasticizers; Polyesters; Polyethylene Glycols; Polymers; Solvents; Vitamin E | 2009 |
Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Lactic Acid; Micelles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Rhodamines; Vitamin E | 2009 |
Preparation of sustained release microparticles with improved initial release property.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Octreotide; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; Vitamin E | 2009 |
Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Docetaxel; Female; Humans; Lactic Acid; Mice; Nanoparticles; NIH 3T3 Cells; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quantum Dots; Taxoids; Vitamin E | 2010 |
Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Topics: Absorbable Implants; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Electrochemistry; Excipients; Humans; Lactic Acid; Light; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Scattering, Radiation; Vitamin E | 2010 |
Technetium-99m-labeled poly(DL-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging.
Topics: Animal Structures; Animals; Cryoprotective Agents; Female; Freeze Drying; Isotope Labeling; Lactic Acid; Lymph Nodes; Microscopy, Atomic Force; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radionuclide Imaging; Rats; Rats, Wistar; Sentinel Lymph Node Biopsy; Surface-Active Agents; Technetium; Tissue Distribution; Vitamin E | 2010 |
Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasmic Granules; Cytosol; Doxorubicin; Drug Carriers; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluoresceins; Fluorescent Dyes; Humans; Lactic Acid; Light; Molecular Structure; Nanoparticles; Particle Size; Photochemotherapy; Photosensitizing Agents; Polyesters; Polyethylene Glycols; Polymers; Porphyrins; Verapamil; Vitamin E | 2011 |
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Topics: Acetates; Centrifugation; Chloroform; Docetaxel; Lactic Acid; Nanocapsules; Nanoparticles; Particle Size; Photoelectron Spectroscopy; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Sonication; Surface Tension; Surface-Active Agents; Taxoids; Vitamin E | 2011 |
Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biocompatible Materials; Biodegradation, Environmental; Cell Line, Tumor; Drug Delivery Systems; Humans; Immunohistochemistry; Lactic Acid; Ligands; Nanoparticles; Nanotechnology; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Surface Properties; Trastuzumab; Vitamin E | 2012 |
Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Emulsions; Humans; Irinotecan; Lactic Acid; Materials Testing; Nanocapsules; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2012 |
Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chemical Precipitation; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Female; Humans; Lactic Acid; Lung Neoplasms; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Survival; Chromatography, Gel; Coumarins; Docetaxel; Female; Humans; Inhibitory Concentration 50; Lactic Acid; Magnetic Resonance Spectroscopy; Mannitol; MCF-7 Cells; Molecular Weight; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Taxoids; Thermogravimetry; Thiazoles; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
Topics: Animals; Anti-Inflammatory Agents; Dexamethasone; Diffusion; Eye Diseases; Intravitreal Injections; Lactic Acid; Materials Testing; Metabolic Clearance Rate; Nanocapsules; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Posterior Eye Segment; Rabbits; Tissue Distribution; Vitamin E | 2013 |
Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Emulsions; Lactic Acid; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Sulfonamides; Surface-Active Agents; Vitamin E | 2014 |
In vitro susceptibilities of wild and drug resistant leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacy.
Topics: Animals; Biological Transport; Capsules; Diterpenes; Drug Interactions; Drug Resistance; Drug Stability; Female; Kinetics; Lactic Acid; Leishmania donovani; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2013 |
A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Oleanolic Acid; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Thiazoles; Vitamin E | 2015 |
Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
Topics: Animals; Carbonic Anhydrase Inhibitors; Glaucoma; Intraocular Pressure; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Ocular Hypertension; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Radionuclide Imaging; Sulfonamides; Thiophenes; Vitamin A; Vitamin E | 2014 |
TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Micelles; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Serum Albumin, Bovine; Vitamin E | 2014 |
Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel.
Topics: Animals; Cell Line, Tumor; Ethanol; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E; Water; Xenograft Model Antitumor Assays | 2014 |
pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biocompatible Materials; Cations; Dioxanes; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Hydrogen-Ion Concentration; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Fluorescence; Oxazoles; Polyesters; Polyethylene Glycols; Polymers; Vitamin E | 2015 |
TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Irinotecan; Lactic Acid; Mitochondria; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2015 |
Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Resistance, Multiple; Female; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Particle Size; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Vitamin E | 2015 |
Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diffusion; Doxorubicin; Lactic Acid; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Vitamin E | 2015 |
Novel PLGA-based nanoparticles for the oral delivery of insulin.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Emulsions; Glucose; Insulin; Lactic Acid; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Vitamin E | 2015 |
Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Humans; Lactic Acid; Lapatinib; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mononuclear Phagocyte System; Nanoparticles; Phagocytosis; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinazolines; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2015 |
Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs.
Topics: Antibiotics, Antineoplastic; DNA, Circular; Doxorubicin; Drug Carriers; Gases; Gene Expression; Lactic Acid; Microspheres; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E; X-Ray Diffraction | 2015 |
Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Topics: Animals; Carcinoma, Hepatocellular; Docetaxel; Drug Delivery Systems; Hep G2 Cells; Humans; Indoles; Lactic Acid; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Taxoids; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer.
Topics: Animals; Drug Carriers; Genistein; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Mannitol; Mice; Mice, SCID; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
The effects of quercetin-loaded PLGA-TPGS nanoparticles on ultraviolet B-induced skin damages in vivo.
Topics: Animals; Antioxidants; Cell Line; Drug Carriers; Female; Humans; Keratinocytes; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Radiation Injuries, Experimental; Skin; Skin Diseases; Ultraviolet Rays; Vitamin E | 2016 |
Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Drug Liberation; Epirubicin; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Mice; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Vitamin E | 2016 |
Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Coumarins; Drug Carriers; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Thiazoles; Vitamin E | 2016 |
Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Diterpenes, Kaurane; Drug Carriers; Drug Liberation; Galactose; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2016 |
Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; HeLa Cells; Humans; Indoles; Lactic Acid; Mice, SCID; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Taxoids; Uterine Cervical Neoplasms; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Topics: Animals; Antineoplastic Agents; Hep G2 Cells; Heparin; Humans; Lactic Acid; Liver Neoplasms; Mice; Nanoparticles; Oleanolic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2016 |
Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Topics: Alginates; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Emulsions; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vincristine; Vitamin E; Xenograft Model Antitumor Assays | 2017 |
Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Caco-2 Cells; Chemistry, Pharmaceutical; Colorectal Neoplasms; Drug Liberation; Emulsifying Agents; Female; Humans; Ibuprofen; Lactic Acid; MCF-7 Cells; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Vitamin E | 2017 |
A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
Topics: Animals; Antineoplastic Agents; Docetaxel; Dopamine; Drug Liberation; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phototherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Vitamin E | 2018 |
Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance.
Topics: alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Glycolates; Humans; Lactic Acid; Liver Neoplasms; Mice; Mice, Nude; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sorafenib; Vitamin E | 2022 |